Swiss National Bank’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Swiss National Bank’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-421,650	Closed	-$717K	–	2552
2018 Q3	$717K	Hold	421,650	–	–	﹤0.01%	2305
2018 Q2	$734K	Hold	421,650	–	–	﹤0.01%	2322
2018 Q1	$772K	Hold	421,650	–	–	﹤0.01%	2224
2017 Q4	$940K	Buy	421,650 +50,000	+13%	+$124K	﹤0.01%	2127
2017 Q3	$1.08M	Hold	371,650	–	–	﹤0.01%	2015
2017 Q2	$1.65M	Buy	371,650 +46,800	+14%	+$193K	﹤0.01%	1712
2017 Q1	$1.51M	Buy	324,850 +34,000	+12%	+$197K	﹤0.01%	1757
2016 Q4	$1.77M	Hold	290,850	–	–	﹤0.01%	1635
2016 Q3	$1.6M	Buy	290,850 +117,500	+68%	+$550K	﹤0.01%	1659
2016 Q2	$659K	Hold	173,350	–	–	﹤0.01%	2202
2016 Q1	$462K	Buy	173,350 +35,050	+25%	+$127K	﹤0.01%	2350
2015 Q4	$784K	Buy	138,300 +12,500	+10%	+$76.2K	﹤0.01%	1986
2015 Q3	$667K	Buy	125,800 +18,800	+18%	+$145K	﹤0.01%	2018
2015 Q2	$888K	Buy	107,000 +8,600	+9%	+$41.7K	﹤0.01%	1863
2015 Q1	$455K	Hold	98,400	–	–	﹤0.01%	2214
2014 Q4	$300K	Hold	98,400	–	–	﹤0.01%	2403
2014 Q3	$274K	Hold	98,400	–	–	﹤0.01%	2361
2014 Q2	$400K	Buy	98,400 +18,700	+23%	+$79.5K	﹤0.01%	2279
2014 Q1	$423K	Buy	79,700 +12,066	+18%	+$67.6K	﹤0.01%	2203
2013 Q4	$376K	Hold	67,634	–	–	﹤0.01%	2164
2013 Q3	$305K	Buy	67,634 +26,364	+64%	+$118K	﹤0.01%	2202
2013 Q2	$176K	Buy	+41,270	New	+$207K	﹤0.01%	2392

Other funds holding SGYP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OCM

Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Swiss National Bank's SGYP Position: Q4 2018 in Review

Swiss National Bank sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 421,650 shares — an estimated $717K sold.

Swiss National Bank first reported a position in SGYP in Q2 2013 and held it in 22 quarters. The position peaked at $1.77M in Q4 2016. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Swiss National Bank reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Swiss National Bank sold 421,650 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $717K.
Swiss National Bank first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 22 quarters.
Swiss National Bank's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.77M in Q4 2016.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Swiss National Bank's 13F filing for Q4 2018, filed 13 Feb 2019.